Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease

European Journal of Neuroscience

Volumn 24, Issue 2, 2006, Pages 361-370

  McLeod, M ^a   Hong, M ^a   Mukhida, K ^a   Sadi, D ^a   Ulalia, R ^a   Mendez, I ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Erythropoietin; Fetal ventral mesencephalon; GDNF; Neural transplantation; Parkinson's disease

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; OXIDOPAMINE; RECOMBINANT ERYTHROPOIETIN;

ANGIOGENESIS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CONVALESCENCE; DOPAMINERGIC NERVE CELL; FEMALE; FETUS; FUNCTIONAL ASSESSMENT; GRAFT SURVIVAL; HIBERNATION; IMMUNOHISTOCHEMISTRY; MEDICAL ASSESSMENT; MESENCEPHALON; NERVE FIBER GROWTH; NERVE GRAFT; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ROTATION; STRIATE CORTEX;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CAPILLARIES; CELL SURVIVAL; CELLS, CULTURED; DRUG SYNERGISM; ERYTHROPOIETIN; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GRAFT SURVIVAL; GROWTH CONES; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE REGENERATION; NEURONAL PLASTICITY; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SUBSTANTIA NIGRA; TREATMENT OUTCOME;

EID: 33746191379     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.04919.x     Document Type: Article

References (91)

1. Anagnostou, A., Lee, E.S., Kessimian, N., Levinson, R. & Steiner, M. (1990) Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl Acad. Sci. USA, 87, 5978-5982.
2. Anagnostou, A., Liu, Z., Steiner, M., Chin, K., Lee, E.S., Kessimian, N. & Noguchi, C.T. (1994) Erythropoietin receptor mRNA expression in human endothelial cells. Proc. Natl Acad. Sci. USA, 91, 3974-3978.
3. Apostolides, C., Sanford, E., Hong, M. & Mendez, I. (1998) Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience, 83, 363-372.
4. Ashley, R.A., Dubuque, S.H., Dvorak, B., Woodward, S.S., Williams, S.K. & Kling, P.J. (2002) Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr Res, 51, 472-478.
5. Baker, K.A., Sadi, D., Hong, M. & Mendez, I. (2000) Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: role of the intranigral graft. J. Comp. Neurol., 426, 106-116.
6. Bao, H., Jacobs-Helber, S.M., Lawson, A.E., Penta, K., Wickrema, A. & Sawyer, S.T. (1999) Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood, 93, 3757-3773.
7. Bernaudin, M., Marti, H.H., Roussel, S., Divoux, D., Nouvelot, A., MacKenzie, E.T. & Petit, E. (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab., 19, 643-651.
8. Bernaudin, M., Bellail, A., Marti, H.H., Yvon, A., Vivien, D., Duchatelle, I., Mackenzie, E.T. & Petit, E. (2000) Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia, 30, 271-278.
9. Bocker-Meffert, S., Rosenstiel, P., Rohl, C., Warneke, N., Held-Feindt, J., Sievers, J. & Lucius, R. (2002) Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Invest. Ophthalmol. Vis. Sci., 43, 2021-2026.
10. Brundin, P., Nilsson, O.G., Strecker, R.E., Lindvall, O., Astedt, B. & Bjorklund, A. (1986) Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res., 65, 235-240.
11. Brundin, P., Strecker, R.E., Widner, H., Clarke, D.J., Nilsson, O.G., Astedt, B., Lindvall, O. & Bjorklund, A. (1988) Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain Res., 70, 192-208.
12. Brundin, P., Pogarell, O., Hagell, P., Piccini, P., Widner, H., Schrag, A., Kupsch, A., Crabb, L., Odin, P., Gustavii, B., Bjorklund, A., Brooks, D.J., Marsden, C.D., Oertel, W.H., Quinn, N.P., Rehncrona, S. & Lindvall, O. (2000) Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain, 123, 1380-1390.
13. Burke, R.E., Antonelli, M. & Sulzer, D. (1998) Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J Neurochem., 71, 517-525.
14. Carlini, R.G., Reyes, A.A. & Rothstein, M. (1995) Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int., 47, 740-745.
15. Choi, D.W. (1988) Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci., 11, 465-469.
16. Choi, D.W. & Rothman, S.M. (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci., 13, 171-182.
17. Chong, Z.Z., Kang, J.Q. & Maiese, K. (2002a) Angiogenesis and plasticity: role of erythropoietin in vascular systems. J. Hematother. Stem Cell Res., 11, 863-871.
18. Chong, Z.Z., Kang, J.Q. & Maiese, K. (2002b) Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation, 106, 2973-2979.
19. Clarkson, E.D., Zawada, W.M. & Freed, C.R. (1995) GDNF reduces apoptosis in dopaminergic neurons in vitro. Neuroreport, 7, 145-149.
20. Clarkson, E.D., Zawada, W.M. & Freed, C.R. (1997) GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro. Cell Tissue Res., 289, 207-210.
21. Crivellato, E., Nico, B., Vacca, A., Djonov, V., Presta, M. & Ribatti, D. (2004) Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo. Leukemia, 18, 331-336.
22. Csete, M., Rodriguez, L., Wilcox, M. & Chadalavada, S. (2004) Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts. Neurosci. Lett., 359, 124-126.
23. Digicaylioglu, M., Bichet, S., Marti, H.H., Wenger, R.H., Rivas, L.A., Bauer, C. & Gassmann, M. (1995) Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl Acad. Sci. USA, 92, 3717-3720.
24. Digicaylioglu, M. & Lipton, S.A. (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature, 412, 641-647.
25. Eggert, K., Schlegel, J., Oertel, W., Wurz, C., Krieg, J.C. & Vedder, H. (1999) Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro. Neurosci. Lett., 269, 178-182.
26. Folkman, J. & Haudenschild, C. (1980) Angiogenesis in vitro. Nature, 288, 551-556.
27. Freed, C.R., Greene, P.E., Breeze, R.E., Tsai, W.Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J.Q., Eidelberg, D. & Fahn, S. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med., 344, 710-719.
28. Freeman, T.B., Olanow, C.W., Hauser, R.A., Nauert, G.M., Smith, D.A., Borlongan, C.V., Sanberg, P.R., Holt, D.A., Kordower, J.H., Vingerhoets, F.J., Snow, B.J., Caine, D. & Gauger, L.L. (1995) Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol., 38, 379-388.
29. Fujikawa, K., de Aos Scherpenseel, I., Jain, S.K., Presman, E., Christensen, R.A. & Varticovski, L. (1999) Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Exp. Cell Res., 253, 663-672.
30. Genc, S., Kuralay, F., Genc, K., Akhisaroglu, M., Fadiloglu, S., Yorukoglu, K., Fadiloglu, M. & Gure, A. (2001) Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neurosci. Lett., 298, 139-141.
31. Hayes, A.J., Huang, W.Q., Mallah, J., Yang, D., Lippman, M.E. & Li, L.Y. (1999) Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc. Res., 58, 224-237.
32. Hebb, A.O., Hebb, K., Ramachandran, A.C. & Mendez, I. (2003) Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage. J Neurosurg., 98, 1078-1083.
33. Hou, J.G., Lin, L.F. & Mytilineou, C. (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4- phenylpyridinium. J. Neurochem., 66, 74-82.
34. Ihle, J.N. (1995) Cytokine receptor signalling. Nature, 377, 591-594.
35. Jaquet, K., Krause, K., Tawakol-Khodai, M., Geidel, S. & Kuck, K.H. (2002) Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc. Res., 64, 326-333.
36. Junk, A.K., Mammis, A., Savitz, S.I., Singh, M., Roth, S., Malhotra, S., Rosenbaum, P.S., Cerami, A., Brines, M. & Rosenbaum, D.M. (2002) Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA, 99, 10659-10664.
37. Juul, S.E., Anderson, D.K., Li, Y. & Christensen, R.D. (1998) Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr. Res., 43, 40-49.
38. Kang, D.H., Park, E.Y., Yu, E.S., Lee, Y.S. & Yoon, K.I. (2005) Renoprotective effect of erythropoietin (EPO): possibly via an amelioration of renal hypoxia with stimulation of angiogenesis in the kidney. Kidney Int., 67, 1683.
39. Kawamoto, J.C. & Barrett, J.N. (1986) Cryopreservation of primary neurons for tissue culture. Brain Res., 384, 84-93.
40. Kertesz, N., Wu, J., Chen, T.H., Sucov, H.M. & Wu, H. (2004) The role of erythropoietin in regulating angiogenesis. Dev. Biol., 276, 101-110.
41. Koblizek, T.I., Weiss, C., Yancopoulos, G.D., Deutsch, U. & Risau, W. (1998) Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol., 8, 529-532.
42. Konishi, Y., Chui, D.H., Hirose, H., Kunishita, T. & Tabira, T. (1993) Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res., 609, 29-35.
43. Kordower, J.H., Freeman, T.B., Snow, B.J., Vingerhoets, F.J., Mufson, E.J., Sanberg, P.R., Hauser, R.A., Smith, D.A., Nauert, G.M., Perl, D.P. & Olanow, C.W (1995) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med., 332, 1118-1124.
44. Lacombe, C. & Mayeux, P. (1998) Biology of erythropoietin. Haematologica, 83, 724-732.
45. Lee, J.Y., Koh, H.C., Chang, M.Y., Park, C.H., Lee, Y.S. & Lee, S.H. (2003) Erythropoietin and bone morphogenetic protein 7 mediate ascorbate-induced dopaminergic differentiation from embryonic mesencephalic precursors. Neuroreport, 14, 1401-1404.
46. Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S. & Collins, F. (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 260, 1130-1132.
47. Lin, L.F., Zhang, T.J., Collins, F. & Armes, L.G. (1994) Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem., 63, 758-768.
48. Lindvall, O., Sawle, G., Widner, H., Rothwell, J.C., Bjorklund, A., Brooks, D., Brundin, P., Frackowiak, R., Marsden, C.D., Odin, P. & Rehncrona, S. (1994) Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol., 35, 172-180.
49. Marsden, C.D. & Parkes, J.D. (1977) Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet, 1, 345-349.
50. Marti, H.H., Wenger, R.H., Rivas, L.A., Straumann, U., Digicaylioglu, M., Henn, Y., Yonekawa, Y., Bauer, C. & Gassmann, M. (1996) Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci., 8, 666-676.
51. Masuda, S., Okano, M., Yamagishi, K., Nagao, M., Ueda, M. & Sasaki, R. (1994) A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J. Biol. Chem., 269, 19488-19493.
52. Mehta, V., Hong, M., Spears, J. & Mendez, I. (1998) Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor. J. Neurosurg., 88, 1088-1095.
53. Mendez, I.M., Naus, C.C., Elisevich, K. & Flumerfelt, B.A. (1993) Normalization of striatal proenkephalin and preprotachykinin mRNA expression by fetal substantia nigra grafts. Exp. Neurol., 119, 1-10.
54. Mendez, I., Sadi, D. & Hong, M. (1996) Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J. Neurosci., 16, 7216-7227.
55. Mendez, I., Sanchez-Pernaute, R., Cooper, O., Vinuela, A., Ferrari, D., Bjorklund, L., Dagher, A. & Isacson, O. (2005) Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain, 128, 1498-1510.
56. Middleton, G., Hamanoue, M., Enokido, Y., Wyatt, S., Pennica, D., Jaffray, E., Hay, R.T. & Davies, A.M. (2000) Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J. Cell Biol., 148, 325-332.
57. Morishita, E., Masuda, S., Nagao, M., Yasuda, Y. & Sasaki, R. (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience, 76, 105-116.
58. Nagai, T., Akizawa, T., Nakashima, Y., Kohjiro, S., Nabeshima, K., Kanamori, N., Takayama, K., Kinugasa, E. & Koshikawa, S. (1995) Effects of rHuEpo on cellular proliferation and endothelin-1 production in cultured endothelial cells. Nephrol. Dial. Transplant., 10, 1814-1819.
59. Nikkhah, G., Cunningham, M.G., McKay, R. & Bjorklund, A. (1995) Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. II. Transplant-induced behavioral recovery. J. Neurosci., 15, 3562-3570.
60. Nutt, J.G. (2003) Long-term L-DOPA therapy: challenges to our understanding and for the care of people with Parkinson's disease. Exp. Neurol., 184, 9-13.
61. Offen, D., Beart, P.M., Cheung, N.S., Pascoe, C.J., Hochman, A., Gorodin, S., Melamed, E., Bernard, R. & Bernard, O. (1998) Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc. Natl Acad. Sci. USA, 95, 5789-5794.
62. Olanow, C.W., Goetz, C.G., Kordower, J.H., Stoessl, A.J., Sossi, V., Brin, M.F., Shannon, K.M., Nauert, G.M., Perl, D.P., Godbold, J. & Freeman, T.B. (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol., 54, 403-414.
63. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, San Diego.
64. Ribatti, D., Presta, M., Vacca, A., Ria, R., Giuliani, R., Dell'Era, P., Nico, B., Roncali, L. & Dammacco, F. (1999) Human erythropoietin induces a proangiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood, 93, 2627-2636.
65. Risau, W. (1997) Mechanisms of angiogenesis. Nature, 386, 671-674.
66. Rolletschek, A., Chang, H., Guan, K., Czyz, J., Meyer, M. & Wobus, A.M. (2001) Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. Mech. Dev., 105, 93-104.
67. Rosenblad, C., Martinez-Serrano, A. & Bjorklund, A. (1996) Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience, 75, 979-985.
68. Ruschitzka, F.T., Wenger, R.H., Stallmach, T., Quaschning, T., de Wit, C., Wagner, K., Labugger, R., Keim, M., Noll, G., Rulicke, T., Shaw, S., Lindberg, R.L., Rodenwaldt, B., Lutz, H., Bauer, C., Luscher, T.F. & Gassmann, M. (2000) Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc. Natl Acad. Sci. USA, 97, 11609-11613.
69. Sadamoto, Y., Igase, K., Sakanaka, M., Sato, K., Otsuka, H., Sakaki, S., Masuda, S. & Sasaki, R. (1998) Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun., 253, 26-32.
70. Sakanaka, M., Wen, T.C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M. & Sasaki, R. (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl Acad. Sci. USA, 95, 4635-4640.
71. Schaller, B., Andres, R.H., Huber, A.W., Meyer, M., Perez-Bouza, A., Ducray, A.D., Seiler, R.W. & Widmer, H.R. (2005) Effect of GDNF on differentiation of cultured ventral mesencephalic dopaminergic and non-dopaminergic calretinin-expressing neurons. Brain Res., 1036, 163-172.
72. Schierle, G.S., Leist, M., Martinou, J.C., Widner, H., Nicotera, P. & Brundin, P. (1999) Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants. Eur. J. Neurosci., 11, 3073-3081.
73. Silva, M., Benito, A., Sanz, C., Prosper, F., Ekhterae, D., Nunez, G. & Fernandez-Luna, J.L. (1999) Erythropoietin can induce the expression of bcl-x (L) through Stat5 in erythropoietin-dependent progenitor cell lines. J. Biol. Chem., 274, 22165-22169.
74. Sinclair, S.R., Svendsen, C.N., Torres, E.M., Martin, D., Fawcett, J.W. & Dunnett, S.B. (1996) GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. Neuroreport, 7, 2547-2552.
75. Siren, A.L. & Ehrenreich, H. (2001) Erythropoietin - a novel concept for neuroprotection. Eur. Arch. Psychiatry Clin. Neurosci., 251, 179-184.
76. Siren, A.L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., Mennini, T., Heumann, R., Cerami, A., Ehrenreich, H. & Ghezzi, P. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl Acad. Sci. USA, 98, 4044-4049.
77. Strömberg, I., Bjorklund, L., Johansson, M., Tomac, A., Collins, F., Olson, L., Hoffer, B. & Humpel, C. (1993) Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol., 124, 401-412.
78. Studer, L., Csete, M., Lee, S.H., Kabbani, N., Walikonis, J., Wold, B. & McKay, R. (2000) Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J. Neurosci., 20, 7377-7383.
79. Suri, C., McClain, J., Thurston, G., McDonald, D.M., Zhou, H., Oldmixon, E.H., Sato, T.N. & Yancopoulos, G.D. (1998) Increased vascularization in mice overexpressing angiopoietin-1. Science, 282, 468-471.
80. Tabira, T., Konishi, Y. & Gallyas, F. Jr (1995) Neurotrophic effect of hematopoietic cytokines on cholinergic and other neurons in vitro. Int. J. Dev. Neurosci., 13, 241-252.
81. Vogel, J., Kiessling, I., Heinicke, K., Stallmach, T., Ossent, P., Vogel, O., Aulmann, M., Frietsch, T., Schmid-Schonbein, H., Kuschinsky, W. & Gassmann, M. (2003) Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood, 102, 2278-2284.
82. Wang, L., Zhang, Z., Wang, Y., Zhang, R. & Chopp, M. (2004) Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke, 35, 1732-1737.
83. Wen, T.C., Sadamoto, Y., Tanaka, J., Zhu, P.X., Nakata, K., Ma, Y.J., Hata, R. & Sakanaka, M. (2002) Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. J. Neurosci. Res., 67, 795-803.
84. Widner, H., Tetrud, J., Rehncrona, S., Snow, B., Brundin, P., Gustavii, B., Bjorklund, A., Lindvall, O. & Langston, J.W. (1992) Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1.2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med., 327, 1556-1563.
85. Wojchowski, D.M., Gregory, R.C., Miller, C.P., Pandit, A.K. & Pircher, T.J. (1999) Signal transduction in the erythropoietin receptor system. Exp. Cell Res., 253, 143-156.
86. Yamaji, R., Okada, T., Moriya, M., Naito, M., Tsuruo, T., Miyatake, K. & Nakano, Y. (1996) Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur. J. Biochem., 239, 494-500.
87. Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J. & Holash, J. (2000) Vascular-specific growth factors and blood vessel formation. Nature, 407, 242-248.
88. Yoshimura, A. & Misawa, H. (1998) Physiology and function of the erythropoietin receptor. Curr. Opin. Hematol., 5, 171-176.
89. Youssoufian, H., Longmore, G., Neumann, D., Yoshimura, A. & Lodish, H.F. (1993) Structure, function, and activation of the erythropoietin receptor. Blood, 81, 2223-2236.
90. Yurek, D.M. (1998) Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue. Exp. Neurol., 153, 195-202.
91. Zawada, W.M., Zastrow, D.J., Clarkson, E.D., Adams, F.S., Bell, K.P. & Freed, C.R. (1998) Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res., 786, 96-103.